Once Daily Gabapentin in the Treatment of Post Amputation Pain
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Phantom limb pain (PLP) is a common disorder reported by the patients who undergo amputation.
Even though the cause of PLP remains unclear, Gabapentin has been widely used. The purpose of
this study is to evaluate the accuracy and efficacy achieved in using of extended release
Gabapentin. Reducing the incidence of chronic post-amputation pain and improving clinical
outcomes postoperatively.